Mexbrain SAS

The goal of this clinical trial is to test the MEX-CD1 hemodialysis medical device in patients suffering from ACLF. The main questions it aims to answer are:
* Is the device safe when used according to the instructions for use?
* Does the device work as expected by removing the excess of free iron from the blood?
Patients will receive 3 MEX-CD1 Slow Low volume CVVHD within 1 week.

The goal of this clinical trial is to test the MEX-CD1 hemodialysis medical device in patients suffering from Wilson's Disease. The main questions it aims to answer are:
* Does the device work as expected by removing the excess of free copper from the blood?
* Is the device safe when used according to the instructions for use?
Depending on the severity of their symptoms, patients will receive either 5 or 10 treatments on consecutive days with the MEX-CD1 hemodialysis medical device.